A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease

Clinical trial NCT04045678 · COMPLETED

Trial details

NCT number: NCT04045678
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2017-10-10
Primary completion: 2019-04-16
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.